Загрузка...
PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV
On the basis of remarkable antitumor activity, programmed death receptor-1 (PD-1) inhibitors pembrolizumab and nivolumab were approved for the treatment of advanced melanoma in the second-line setting following progression on either CTLA-4 inhibitor ipilimumab or BRAF/MEK inhibitors (for BRAF mutate...
Сохранить в:
| Опубликовано в: : | Case Rep Oncol Med |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4581502/ https://ncbi.nlm.nih.gov/pubmed/26448890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/737389 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|